Top

Molecular Cancer

Published in:

Open Access 01-12-2006 | Research

Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase

Published in: Molecular Cancer | Issue 1/2006

Title: Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase
Publication date: 01-12-2006
Published in: Molecular Cancer / Issue 1/2006
Electronic ISSN: 1476-4598
DOI: https://doi.org/10.1186/1476-4598-5-66

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2006

Pathway-specific differences between tumor cell lines and normal and tumor tissue cells

Early expression of the Helicase-Like Transcription Factor (HLTF/SMARCA3) in an experimental model of estrogen-induced renal carcinogenesis

MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERα) in regulation of the MUC1 gene expression

SMC3 knockdown triggers genomic instability and p53-dependent apoptosis in human and zebrafish cells

Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo

Overexpression of Eag1 potassium channels in clinical tumours

Keynote webinar | Spotlight on antibody–drug conjugates in cancer